Quest Diagnostics Inc. DGX
$234.40
-0.69%
at last close
Analyst Consensus
- Consensus Rating
- Hold (4 Buy · 7 Hold · 0 Sell)
- Average Price Target
- $232.00
- Implied Upside
- -1.0%
- Price Target Range
- $200.00 – $260.00
- Analysts (12 mo)
- 11
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-07-28 | JP MorganLisa Gill |
Maintains | Neutral | $220 → $250 |
| 2026-07-24 | UBSKevin Caliendo |
Maintains | Neutral | $220 → $232 |
| 2026-07-24 | MizuhoAnn Hynes |
Maintains | Outperform | $235 → $260 |
| 2026-07-24 | Truist SecuritiesDavid Macdonald |
Maintains | Hold | $225 → $250 |
| 2026-07-24 | BarclaysLuke Sergott |
Maintains | Overweight | $230 → $250 |
| 2026-07-24 | BairdEric Coldwell |
Maintains | Neutral | $236 → $255 |
| 2026-07-13 | BairdEric Coldwell |
Maintains | Neutral | $232 → $236 |
| 2026-04-22 | UBSKevin Caliendo |
Maintains | Neutral | $210 → $220 |
| 2026-04-22 | BairdEric Coldwell |
Maintains | Neutral | $224 → $229 |
| 2026-04-22 | BarclaysLuke Sergott |
Maintains | Overweight | $225 → $230 |
| 2026-04-22 | Truist SecuritiesDavid Macdonald |
Maintains | Hold | $220 → $225 |
| 2026-04-08 | Evercore ISI GroupElizabeth Anderson |
Maintains | In-line | $220 → $210 |
| 2026-02-12 | MizuhoAnn Hynes |
Maintains | Outperform | $210 → $235 |
| 2026-02-11 | Truist SecuritiesDavid Macdonald |
Maintains | Hold | $205 → $220 |
| 2026-02-11 | UBSKevin Caliendo |
Maintains | Neutral | $190 → $210 |
| 2026-02-11 | Evercore ISI GroupElizabeth Anderson |
Maintains | In-line | $190 → $220 |
| 2026-02-11 | BarclaysStephanie Davis |
Maintains | Overweight | $210 → $225 |
| 2026-02-11 | JefferiesTycho Peterson |
Maintains | Buy | $215 → $220 |
| 2026-02-10 | CitigroupPatrick Donnelly |
Maintains | Neutral | $190 → $215 |
| 2025-10-27 | Piper SandlerDavid Westenberg |
Maintains | Neutral | $190 → $200 |
| 2025-10-22 | BarclaysStephanie Davis |
Maintains | Equal-weight | $190 → $195 |
| 2025-10-22 | Truist SecuritiesDavid Macdonald |
Maintains | Hold | $195 → $205 |
| 2025-10-21 | Leerink PartnersMichael Cherny |
Maintains | Outperform | $203 → $210 |
| 2025-10-21 | JefferiesTycho Peterson |
Maintains | Buy | $200 → $215 |
| 2025-10-17 | UBSKevin Caliendo |
Maintains | Neutral | $180 → $190 |
| 2025-10-17 | MizuhoAnn Hynes |
Maintains | Outperform | $190 → $210 |
| 2025-10-08 | Evercore ISI GroupElizabeth Anderson |
Maintains | In-line | $185 → $190 |
| 2025-10-02 | BarclaysStephanie Davis |
Maintains | Equal-weight | $185 → $190 |
| 2025-08-25 | BairdEric Coldwell |
Downgrades | Outperform → Neutral | $194 |
| 2025-07-23 | UBSKevin Caliendo |
Maintains | Neutral | $175 → $180 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $234.40
- Market Cap
- $26.24 billion
- 52-Week Range
- $164.65 – $240.13
- Average Volume
- 987K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.